The relationships between acute and chronic radiation side effects are controversial and the prediction of their severity is difficult [15]. Although oesophageal symptoms are common during adjuvant thoracic RT, the effects of irradiation on oesophageal function are still to be assessed.
Oesophagitis arises in at least two-thirds of patients undergoing mediastinal RT. EORTC-RTOG grade 2 and grade 3 oesophagitis occurs in 12% and 3% of patients respectively [16]. In the majority of patients, it's onset is during the third week of the RT course. Any concomitant chemotherapy and simultaneous exposure of the organ to exogenous infectious agents by micro-traumatising agents (mainly some foods) increases the risk of radiation toxicity.
Around one third of patients develop clinical symptoms without histological changes [17] and endoscopic and radiographic identification and quantification of subtle disorders remains a problem.
Patients with clinical signs of acute radiation oesophagitis often have negative single-contrast oesophagograms [18] and only in a few positive cases was a thin indentation of the barium column demonstrated. Double contrast radiological examination may reveal a variable segment of oesophageal narrowing with multiple discrete ulcers or a distinctive granular appearance of the mucosa within a known irradiated volume, suggesting the diagnosis of radiation oesophagitis [19], but a quantitative evaluation of altered oesophageal transit cannot be assessed.
Endoscopic studies may show oedema and vulnerability of the mucosa without erosion in patients with clinical signs of radiation-induced oesophagitis [20], but additional dynamic visual analysis might be helpful in diagnosing early changes.
Oesophageal scintigraphy is a well-established nuclear imaging method for the detection of motility disorders that has been used in a variety of clinical situations such as systemic sclerosis, oesophageal spasm, achalasia [21], diabetes mellitus [22], reflux disease and dysphagia of unclear origin. It is a non-invasive diagnostic method with a low radiation dose and offers the possibility of quantitative analysis.
The clinical, value of radionuclide oesophageal transit measurements in relation to established oesophageal motility investigations, was assessed by de Caestecker et al. [23]. In their experience of 150 patients, the overall sensitivity in detecting oesophageal dysmotility was 75% for radionuclide transit measurements, 83% for manometry and 30% for conventional barium radiology. In 18 patients oesophageal scans identified abnormalities not detected by manometry. The authors concluded that radionuclide transit measurements were a useful test for patients with suspected oesophageal motility disorders, providing additional information which complemented oesophageal manometry, although it did have limitations as a screening test. The validity of non-invasive oesophageal transit scintigraphy to quantitatively assess gastrointestinal motor dysfunction has been supported by a number of other studies and reviews [24–27].
According to Holloway et al. [28], the main limitation of the radionuclide transit test may be a consequence of using a liquid bolus. This successfully identifies motor disorders characterized by defective peristaltic progression but fails to discover disorders in which peristalsis is intact, probably because of the small number of swallow sequences tested.
Dysphagia and odynophagia are the symptoms most commonly experienced by patients with acute radiation oesophagitis [1], but objective documentation of early dysphagia remains difficult. The rate of mild (grade 1) toxicity ranges between 60% and 100% in published series. Dysphagia and odynophagia are clinical manifestations of dyskinesia and mucositis, respectively, suggesting a potential role for oesophageal transit studies in providing prognostic data for early treatment phase evaluation of radiation oesophagitis.
In order to further clarify the pathogenesis of these sequelae, Yeoh et al. [29] used barium swallow, endoscopy, combined radionuclide scintigraphy and oesophageal manometry to evaluate eight patients before, during and after mediastinal irradiation for potentially curable intra-thoracic malignant disease. The authors concluded that post-radiation oesophageal symptoms are not a result of altered oesophageal motility or transit but may reflect increased mucosal sensitivity.
The absence of observed abnormal peristaltic response conflicts with the previous prospective study of LaManna et al. [30] suggesting that post-radiation oesophageal symptoms may reflect disordered oesophageal motility as evaluated by radionuclide oesophageal transit scintigraphy.
This discrepancy may be attributed to differences in methodology of the studies and patient selection criteria, both inducing prolongation of the oesophageal transit time in the LaManna et al. study. In the Yeoh et al. study, the absence of significant changes in oesophageal motility despite the development of symptoms may have been influenced by the inclusion of 3 patients (37%) with carcinoma of the breast. The dose to the oesophagus in those patients was approximately one third of the dose received by the other participants on the study. In addition, a number of patients had underlying abnormalities in oesophageal function which may have masked any small increase in oesophageal transit times.
Oesophageal scintigraphy has also been found to be a sensitive tool for the evaluation of dysphageal symptoms and quantification of the effect of local analgesic treatment during mediastinal RT in a study by Brandt-Mainz et al. [31].
The exact role of oesophageal transit scintigraphy in the evaluation of gastrointestinal motility disease remains controversial. It appears useful when oesophageal manometry is poorly tolerated, such as in patients suffering from acute radiation oesophagitis.
There is a large dependence of measurements on multiple variables such as the patient's position, projection, bolus consistency and volume, isotope, number of independent wet swallows, analytical parameters used, and consideration of age. [32]. Therefore a protocol based on both published data and accumulated local experience is recommended and normal ranges should be defined in one's own laboratory.
The emptying rate (ER) and the mean transit time (MTT) are among the most commonly used parameters for evaluation of oesophageal transit and have already been suggested for the assessment of radiation related oesophageal disorders (Brandt-Mainz et al.).
The originality of our study lies in the evaluation of oesophageal transit time parameters by a non-invasive and well-tolerated method of oesophageal scintigraphy. We hypothesised that patients submitted to mediastinal RT, whether symptomatic or not, might have early impaired oesophageal transit evaluable with this technique.
One of the main strengths of our study, when compared to previous studies, is the homogeneous sample population and treatment technique. All patients received 46 Gy to at least a 12 cm length of oesophagus with a uniform radiation technique and fields. Given the significant volume of oesophagus contained within the full dose region, all patients were at high risk of developing radiation-induced oesophagitis. All patients did, infact, develop grade 1 toxicity during the third week of treatment and all were symptomatic at the time of the T2 study. No patients suffered from grade 2 or 3 radiation oesophagitis. This was most likely due to the absence of concomitant chemotherapy and the lower total dose of irradiation used in the adjuvant setting.
An additional strength of our study is in the timing of oesophageal scintigraphy during the RT course. To our knowledge, this is the largest study of oesophageal transit during RT and the only one in which the scintigraphy is performed at the end of the first and the third week of RT, with the aim of assessing early alterations. The T2 study aimed to detect changes in oesophageal motility during or soon after the symptoms of oesophagitis would generally appear (i.e. around the third week). By contrast, the T1 study was performed after only one week of RT in an attempt to identify any earlier signs of dysmotility that may predict for the subsequent development of symptomatic acute oesophagitis. The reason to perform this early (T1) documentation of transit was also supported by studies of fractionated RT in dogs showing that gastrointestinal motility changes occur within 48 hours of the initiation of therapy [33, 34].
A limitation of this study is the lack of a comparison with manometry, which has been considered the most sensitive method to detect impaired oesophageal motility and lower oesophageal sphincter dysfunction. Kjellen et al., however, have reported on the utility of oesophageal scintigraphy in 16 patients with symptomatic dysphagia but having normal manometry, acid perfusion, acid clearance and pH reflux tests [35]. They concluded that scintigraphy could be regarded as a valuable complement in the objective documentation of dysphagia when other diagnostic methods fail.
Our study found a trend from T0 to further studies in the mean ER-40s value and this was confirmed in the detailed analysis in 9 of 11 patients (81.8%). These differences were not statistically significant (p > 0.05) at ANOVA but two parameters, overall mean ER-40s (p = 0.041) and upright ER-40s (p = 0.032), had changes between the baseline study (T0) and the study performed after three weeks of treatment (T2) which were statistically significant at the paired t-Test analysis.
We acknowledge that the statistical significance of our results is limited despite our homogeneous sample population and treatment technique. However, in view of the high variation in measurements between people, a large sample size would be needed to draw further conclusions. We believe there would be little chance of detecting something more (ie. ANOVA or p < 0.002 with Bonferroni paired t-Tests) with further studies.
Finally, our study was designed about 10 years ago. Since then indications for adjuvant or radical treatment of non-small-cell lung cancer have changed resulting in a dramatic increase in the use of sequential and concomitant chemotherapy with conformal RT and a more limited volume of oesophagus being irradiated (though often to a higher dose). Therefore, it is unlikely that a similar subgroup of patients will be available in the near future for enrolment in a comparable clinical trial as further studies will most likely focus on the effects and changes due to intensive combined modality treatments.